Yenong Cao, MD, PhD, is a medical oncologist specializing in gastrointestinal cancers at Boston Medical Center, and an assistant professor at Boston University Chobanian & Avedisian School of Medicine. Dr. Cao received her doctorate degree in molecular and cellular pharmacology, and medical degree from University of Miami Miller School of Medicine in Miami, Florida. She completed Internal Medicine residency at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, followed by Hematology and Oncology fellowship at Tufts Medical Center in Boston, Massachusetts.
Dr. Cao’s research interests include cancer care delivery equity and patient experience optimization, with a special focus in health technology.
Dr. Cao has authored various publications. She's also the recipient of the Journal of Clinical Oncology (JCO) Oncology Practice Editorial Fellowship and serves as a mentor for the JCO Trainee reviewer mentoring program. She's passionate about advising oncology trainees from diverse backgrounds, and support trainee wellbeing especially new trainee parents.
Diversity, Equity, Inclusion and Accessibility
As a first generation Chinese immigrant and a woman, I place diversity, equity, inclusion and justice central to my career and my personal life. I am passionate in supporting trainees, especially those from minority background, to achieve their career goals.
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Cao Y, Baiyee MNB, Ching J, Murphy-Banks R, Wang FQ, Maloney A, Rodday AM, Parsons SK. Epic Patient Portal Adoption Among Vulnerable Oncology Patients in the Era of Oral Anticancer Medications. JCO Oncol Pract. 2025 Nov 19; OP2500630. PMID: 41259725; DOI: 10.1200/OP-25-00630;
-
Cao Y, Baiyee MNB, Ching J, Murphy-Banks R, Wang F, Maloney A, Rodday AM, Parsons SK. HSR25-151: EPIC Patient Portal Functionality: An Equity Analysis in Vulnerable Cancer Patients. J Natl Compr Canc Netw. 2025 Mar 28; 23(3.5). PMID: 40154383; DOI: 10.6004/jnccn.2024.7319;
-
Parsons SK, Rodday AM, Upshaw JN, Scharman CD, Cui Z, Cao Y, Tiger YKR, Maurer MJ, Evens AM. Harnessing multi-source data for individualized care in Hodgkin Lymphoma. Blood Rev. 2024 May; 65:101170. PMID: 38290895; PMCID: PMC11382606; DOI: 10.1016/j.blre.2024.101170;
-
Cao Y, Liu MC, Hanlon EL, Chen Y, Afzal MZ, Hayes CA, Hill JM. Clinical presentation of Warburg effect in aggressive lymphoma: a case report. J Med Case Rep. 2023 Aug 23; 17(1):380. PMID: 37608348; PMCID: PMC10464222; DOI: 10.1186/s13256-023-04079-6;
-
Zheng S, Cao Y, Randall J, Yu H, Thomas TO. Integrating POLE/POLD1 mutated for immunotherapy treatment planning of advanced stage non-small cell lung cancer. Thorac Cancer. 2023 Aug; 14(23):2269-2274. PMID: 37345618; PMCID: PMC10423654; DOI: 10.1111/1759-7714.15012;
-
Cao Y, Afzal MZ, Shirai K. Ipilimumab and nivolumab induced immune-related adverse events in metastatic mucosal melanoma. BMJ Case Rep. 2021 Aug 20; 14(8). PMID: 34417242; PMCID: PMC8381294; DOI: 10.1136/bcr-2021-243713;
-
Cao Y, Afzal MZ, Shirai K. Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors. J Thorac Dis. 2021 Aug; 13(8):4668-4677. PMID: 34527308; PMCID: PMC8411139; DOI: 10.21037/jtd-21-150;
-
Moon Y, Cao Y, Zhu J, Xu Y, Balkan W, Buys ES, Diaz F, Kerrick WG, Hare JM, Percival JM. GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and Activity. Antioxid Redox Signal. 2017 Feb 01; 26(4):165-181. PMID: 27412893; PMCID: PMC5278832; DOI: 10.1089/ars.2015.6548;
-
-
Hatzistergos KE, Paulino EC, Dulce RA, Takeuchi LM, Bellio MA, Kulandavelu S, Cao Y, Balkan W, Kanashiro-Takeuchi RM, Hare JM. S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction. J Am Heart Assoc. 2015 Jul 15; 4(7). PMID: 26178404; PMCID: PMC4608081; DOI: 10.1161/JAHA.115.001974;
Showing 10 of 14 results.
Show More
-
Cao Y, Gomes SA, Rangel EB, Paulino EC, Fonseca TL, Li J, Teixeira MB, Gouveia CH, Bianco AC, Kapiloff MS, Balkan W, Hare JM. S-nitrosoglutathione reductase-dependent PPAR? denitrosylation participates in MSC-derived adipogenesis and osteogenesis. J Clin Invest. 2015 Apr; 125(4):1679-91. PMID: 25798618; PMCID: PMC4396480; DOI: 10.1172/JCI73780;
-
Gonzalez DR, Treuer AV, Lamirault G, Mayo V, Cao Y, Dulce RA, Hare JM. NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2014 Sep 01; 307(5):H710-21. PMID: 25015966; PMCID: PMC4187396; DOI: 10.1152/ajpheart.00890.2013;
-
Liu H, Kurtoglu M, Cao Y, Xi H, Kumar R, Axten JM, Lampidis TJ. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells. Cancer Chemother Pharmacol. 2013 Jul; 72(1):251-62. PMID: 23700291; DOI: 10.1007/s00280-013-2193-y;
-
Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, Balkan W, Rodrigues CO, Schally AV, Hare JM. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc Natl Acad Sci U S A. 2013 Feb 19; 110(8):2834-9. PMID: 23288904; PMCID: PMC3581904; DOI: 10.1073/pnas.1220185110;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
2025 Conquer Cancer ASCO Quality Care Symposium:
Merit Award
2024-2025 JCO Oncology Practice:
ASCO’s Editorial Fellowship
2021 Northern New England Clinical Oncology Society:
Top Three Poster, Spring Conference
2020 American College of Physicians:
Poster Competition Second Place, New Hampshire Chapter Virtual Meeting
2012-2014 American Heart Association:
Pre-doctoral Fellowship
2011 University of Miami Miller School of Medicine, Miami, FL:
Certificate of Academic Excellence
2009 Fudan University, Shanghai, China:
Scholarship of Academic Excellence